Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
마비 관련 키나아제는 SARS-CoV-2 감염에 필요하며 항바이러스 전략의 세포 표적입니다
Article
[키워드] AAK1
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
antiviral strategy
approach
approaches
approved
caused
cellular
combination treatment
coronavirus
coronavirus disease
Coronavirus disease 2019
COVID-19
demonstrated
drugs
epithelial cells
Erlotinib
experiment
expression
functional
GAK
Genetic
global health
Health
Host-targeted antivirals
human lung
human lung epithelial cells
implication
in vitro
inhibited
kinase
kinase inhibitors
kinases
late stage
life cycle
multiple RNA viruses
multiple RNA viruses
Numb
Numb-associated kinases
other coronaviruses
pandemic
pharmacological
principle
probe
reported
required
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infection in vitro
SARS-CoV-2 life cycle
SARS-CoV-2 pseudovirus
SARS-CoV-2.
severe acute respiratory syndrome Coronavirus
siRNA
small molecule
STK16
sunitinib
suppressed
synergistic
synergistic effect
target
the SARS-CoV-2
threat
treat
viral entry
wild type
[DOI] 10.1016/j.antiviral.2022.105367 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.antiviral.2022.105367 PMC 바로가기 [Article Type] Article